Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Mar 28;2018:bcr2018224978.
doi: 10.1136/bcr-2018-224978.

Beau's Lines

Affiliations
Free PMC article
Case Reports

Beau's Lines

Aditya Jandial et al. BMJ Case Rep. .
Free PMC article

Abstract

No abstract available

Keywords: dermatology; drugs and medicines; haematology (drugs and medicines); malignant and benign haematology.

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Clinical photograph of the patient’s nail in bird’s-eye view showing ridges over nail (A). Side on view showing horizontal ridges with trough in between, typical of Beau’s line (B).

Similar articles

  • [Beau's lines].
    Raimondi A, Carena A, Gómez-Centurión I, Paolicchi N, Alvarez PA. Raimondi A, et al. Medicina (B Aires). 2011;71(6):554. Medicina (B Aires). 2011. PMID: 22167732 Spanish. No abstract available.
  • Images in clinical medicine. Beau's lines.
    Mortimer NJ, Mills J. Mortimer NJ, et al. N Engl J Med. 2004 Oct 21;351(17):1778. doi: 10.1056/NEJMicm040187. N Engl J Med. 2004. PMID: 15496627 No abstract available.
  • Brachial plexopathy affecting the development of Beau's lines unilaterally.
    Camidge DR, Cameron DA. Camidge DR, et al. Lancet Oncol. 2001 Jun;2(6):342. doi: 10.1016/s1470-2045(00)00388-0. Lancet Oncol. 2001. PMID: 11905750 No abstract available.
  • Miscellaneous nail presentations.
    Bodman MA. Bodman MA. Clin Podiatr Med Surg. 1995 Apr;12(2):327-46. Clin Podiatr Med Surg. 1995. PMID: 7600507 Review.
  • Drug-induced nail abnormalities.
    Piraccini BM, Iorizzo M, Antonucci A, Tosti A. Piraccini BM, et al. Expert Opin Drug Saf. 2004 Jan;3(1):57-65. doi: 10.1517/14740338.3.1.57. Expert Opin Drug Saf. 2004. PMID: 14680462 Review.
See all similar articles

Publication types

Substances

LinkOut - more resources

Feedback